相关实验视频

Updated: Aug 15, 2026

Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations

Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations

Published on: August 4, 2016

针对性测序的选择功能基因在患者与野生类型的 transthyretin 氨基化症

Inmaculada Moreno-Gázquez^1,2, Raquel Pérez-Palacios^3,4, Lucia Abengochea-Quílez^5,6,4

¹Department of Clinical Biochemistry, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain. 783161@unizar.es.

BMC research notes

|October 2, 2023

概括

这项研究探讨了野生类型的转氨基粉症 (ATTRwt) 的遗传因素. 研究人员发现了可能与ATTRwt粉样化症相关的新型基因变异,为其发展提供了新的见解.

科学领域:

遗传学是一个遗传学.
分子生物学分子生物学
心脏病学心脏病学

背景情况:

野生类型的转基因氨基化症 (ATTRwt) 是由于转基因 (TTR) 蛋白质错误折叠和沉积而导致的,而没有TTR基因突变.
除了TTR突变之外的遗传因素,例如其他基因中的单核酸多态 (SNP),可能会影响ATTRwt的发展.
对ATTRwt病原体的特定遗传贡献者仍然在很大程度上是未知的.

研究的目的:

调查可能影响ATTRwt amyloidosis的基因中的序列变异的存在.
识别与ATTRwt.的病原性相关的新型遗传因素.

主要方法:

针对84个蛋白质编码基因进行了向测序.
分析了被诊断为ATTRwt的27名患者的队列.
应用了质量和频率过标准来识别罕见或新型变异.

主要成果:

在过后,发现了72种罕见或新型遗传变异.
在14个不同的基因中,有17种变异被归类为具有不确定的意义 (ACMG-AMP标准).
这是第一个将新型编码基因变异与ATTRwt粉样化症联系起来的报告.

结论:

这项研究提供了潜在的洞察力,了解ATTRwt Amyloidosis的病原性.
新的编码基因变异与ATTRwt.的发生有关.
需要进一步的研究来阐明这些变体在ATTRwt发展中的作用.

关键词:

ATTRwt 氨基粉症基因变体的基因变体有针对性的测序.转二氨基化症的发生.

更多相关视频

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations

Published on: March 29, 2017

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Published on: June 9, 2018

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...